MedTrace Logo

The Use of 3D Surface Imaging in the Objective Assessment of Breast Conserving Therapy

NCT02304614 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 346

Last updated 2020-10-22

No results posted yet for this study

Summary

3D surface imaging has been used in the objective evaluation of cosmetic outcome of oncoplastic procedures such as breast reconstruction and lipofilling, however there is only one article published relating to Breast Conserving Therapy (BCT).

The aim of this study is to assess the use 3D surface imaging as a tool in the assessment of symmetry of outcome following breast conserving therapy. The results of the surface imaging will be correlated with patient satisfaction, using the BREAST-Q, which is a validated patient questionnaire and correlated with panel assessment by an independent panel of two surgeons, one clinical oncologist and one breast care nurse.

Conditions

Interventions

OTHER

3D surface imaging using a non portable and portable camera

The participant will have 3D surface imaging taken of their breasts (the face will not be shown)

OTHER

Patient reported outcome measure (PROM): BREAST-Q

The participant will answer the BREAST-Q questionnaire. This is a patient reported outcome measurement of satisfaction and quality of life after BCT

OTHER

2D photography

The participant will have standard medical photography of their breasts (the face will not be shown)

OTHER

Applanation Tonometry

A small 300g disc is placed on the breast to measure the surface area of contact with the breast to measure compressibility

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Jennifer E Rusby, DM FRCS · Royal Marsden NHS Foundation Trust

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-01
Primary Completion
2017-03-22
Completion
2020-12-24

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02304614 on ClinicalTrials.gov